335 related articles for article (PubMed ID: 21892180)
1. A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis.
Sweeney KA; Dao DN; Goldberg MF; Hsu T; Venkataswamy MM; Henao-Tamayo M; Ordway D; Sellers RS; Jain P; Chen B; Chen M; Kim J; Lukose R; Chan J; Orme IM; Porcelli SA; Jacobs WR
Nat Med; 2011 Sep; 17(10):1261-8. PubMed ID: 21892180
[TBL] [Abstract][Full Text] [Related]
2. Tuberculosis vaccine promises sterilizing immunity.
McShane H; Williams A
Nat Med; 2011 Oct; 17(10):1185-6. PubMed ID: 21988991
[No Abstract] [Full Text] [Related]
3. Identification of Mycobacterial RplJ/L10 and RpsA/S1 Proteins as Novel Targets for CD4
Johnson AJ; Kennedy SC; Lindestam Arlehamn CS; Goldberg MF; Saini NK; Xu J; Paul S; Hegde SS; Blanchard JS; Chan J; Jacobs WR; Sette A; Porcelli SA
Infect Immun; 2017 Apr; 85(4):. PubMed ID: 28115505
[TBL] [Abstract][Full Text] [Related]
4. Natural and trained innate immunity against Mycobacterium tuberculosis.
Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
[TBL] [Abstract][Full Text] [Related]
5. Prime-boost with Mycobacterium smegmatis recombinant vaccine improves protection in mice infected with Mycobacterium tuberculosis.
Junqueira-Kipnis AP; de Oliveira FM; Trentini MM; Tiwari S; Chen B; Resende DP; Silva BD; Chen M; Tesfa L; Jacobs WR; Kipnis A
PLoS One; 2013; 8(11):e78639. PubMed ID: 24250805
[TBL] [Abstract][Full Text] [Related]
6. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterium tuberculosis Rv1987 induces Th2 immune responses and enhances Mycobacterium smegmatis survival in mice.
Sha S; Shi X; Deng G; Chen L; Xin Y; Ma Y
Microbiol Res; 2017 Apr; 197():74-80. PubMed ID: 28219528
[TBL] [Abstract][Full Text] [Related]
8. Intranasal immunization with Mycobacterium tuberculosis Rv3615c induces sustained adaptive CD4
Li J; Zhao J; Shen J; Wu C; Liu J
J Cell Mol Med; 2019 Jan; 23(1):596-609. PubMed ID: 30353641
[TBL] [Abstract][Full Text] [Related]
9. Identification of Mycobacterial Ribosomal Proteins as Targets for CD4
Kennedy SC; Johnson AJ; Bharrhan S; Lindestam Arlehamn CS; Xu J; Garforth SJ; Chan J; Jacobs WR; Sette A; Almo SC; Porcelli SA
Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29891545
[No Abstract] [Full Text] [Related]
10. Mycobacterial Lipoprotein Z Triggers Efficient Innate and Adaptive Immunity for Protection Against
Chen Y; Xiao JN; Li Y; Xiao YJ; Xiong YQ; Liu Y; Wang SJ; Ji P; Zhao GP; Shen H; Lu SH; Fan XY; Wang Y
Front Immunol; 2018; 9():3190. PubMed ID: 30700988
[TBL] [Abstract][Full Text] [Related]
11. Recombinant Mycobacterium smegmatis expressing an ESAT6-CFP10 fusion protein induces anti-mycobacterial immune responses and protects against Mycobacterium tuberculosis challenge in mice.
Zhang H; Peng P; Miao S; Zhao Y; Mao F; Wang L; Bai Y; Xu Z; Wei S; Shi C
Scand J Immunol; 2010 Oct; 72(4):349-57. PubMed ID: 20883320
[TBL] [Abstract][Full Text] [Related]
12. Cellular and humoral immunogenicity of recombinant Mycobacterium smegmatis expressing Ag85B epitopes in mice.
Kadir NA; Sarmiento ME; Acosta A; Norazmi MN
Int J Mycobacteriol; 2016 Mar; 5(1):7-13. PubMed ID: 26927984
[TBL] [Abstract][Full Text] [Related]
13. Innate and acquired immune responses to mycobacterial infections: involvement of IL-17A/IL-23 axis in protective immunity.
Umemura M; Matsuzaki G
Nihon Hansenbyo Gakkai Zasshi; 2013 Dec; 82(3):123-32. PubMed ID: 24579460
[TBL] [Abstract][Full Text] [Related]
14. Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits Mycobacterium smegmatis-induced cytokine production by human macrophages in vitro.
Post FA; Manca C; Neyrolles O; Ryffel B; Young DB; Kaplan G
Infect Immun; 2001 Mar; 69(3):1433-9. PubMed ID: 11179309
[TBL] [Abstract][Full Text] [Related]
15. Enhanced priming of adaptive immunity by Mycobacterium smegmatis mutants with high-level protein secretion.
Taylor N; Bahunde F; Thompson A; Yu JS; Jacobs WR; Letvin NL; Haynes BF; Lee S
Clin Vaccine Immunol; 2012 Sep; 19(9):1416-25. PubMed ID: 22787192
[TBL] [Abstract][Full Text] [Related]
16. ESX Secretion-Associated Protein C From
Guo Q; Bi J; Li M; Ge W; Xu Y; Fan W; Wang H; Zhang X
Front Cell Infect Microbiol; 2019; 9():158. PubMed ID: 31134163
[No Abstract] [Full Text] [Related]
17. Recombinant M. smegmatis vaccine targeted delivering IL-12/GLS into macrophages can induce specific cellular immunity against M. tuberculosis in BALB/c mice.
Yi Z; Fu Y; Yang C; Li J; Luo X; Chen Q; Zeng W; Jiang S; Jiang Y; He Y; Yang J; Liu Y; Li N; Zhu DY
Vaccine; 2007 Jan; 25(4):638-48. PubMed ID: 17000035
[TBL] [Abstract][Full Text] [Related]
18. Anti-tuberculosis immunity induced in mice by vaccination with Mycobacterium smegmatis over-expressing Antigen 85B is due to the increased influx of IFNgamma-positive CD4 T cells into the lungs.
Lindsey DR; Dhandayuthapani S; Jagannath C
Tuberculosis (Edinb); 2009 Dec; 89 Suppl 1(Suppl 1):S46-8. PubMed ID: 20006304
[TBL] [Abstract][Full Text] [Related]
19. Sterilization by Adaptive Immunity of a Conditionally Persistent Mutant of Mycobacterium tuberculosis.
Vilchèze C; Porcelli SA; Chan J; Jacobs WR
mBio; 2021 Jan; 12(1):. PubMed ID: 33468684
[No Abstract] [Full Text] [Related]
20. CD4+ T Cells Recognizing PE/PPE Antigens Directly or via Cross Reactivity Are Protective against Pulmonary Mycobacterium tuberculosis Infection.
Sayes F; Pawlik A; Frigui W; Gröschel MI; Crommelynck S; Fayolle C; Cia F; Bancroft GJ; Bottai D; Leclerc C; Brosch R; Majlessi L
PLoS Pathog; 2016 Jul; 12(7):e1005770. PubMed ID: 27467705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
